HCID 18185015、化合物 → HCID 178422560、化合物
反応式
[CH3:1][C:2]1[N:6]([C@@H:7]2[CH2:12][CH2:11][C@H:10]([NH2:13])[CH2:9][CH2:8]2)[C:5]2[CH:14]=[CH:15][C:16]([CH3:18])=[CH:17][C:4]=2[N:3]=1.[F:19][C:20]([F:33])([F:32])[C:21]1[CH:22]=[C:23]2[C:27](=[CH:28][CH:29]=1)[CH2:26][CH:25]([CH:30]=O)[CH2:24]2>>[CH3:1][C:2]1[N:6]([C@@H:7]2[CH2:8][CH2:9][C@H:10]([NH:13][CH2:30][CH:25]3[CH2:24][C:23]4[C:27](=[CH:28][CH:29]=[C:21]([C:20]([F:19])([F:32])[F:33])[CH:22]=4)[CH2:26]3)[CH2:11][CH2:12]2)[C:5]2[CH:14]=[CH:15][C:16]([CH3:18])=[CH:17][C:4]=2[N:3]=1参加物
3
実験手順
This compound was prepared from the hydrochloride salt of cis-4-(2,5-dimethyl-benzoimidazol-1-yl)-cyclohexylamine and 5-trifluoromethyl-indan-2-carbaldehyde. 1H-NMR is consistent with the assigned structure, LC-MS showed a single peak, C26H30F3N3 (m/e) calcd 441.2392, obsd 442.2 (M+H).
出典と根拠
- ORDレコード
- ord-218a644cd6ac470c85a914d0e2a58b22
- 出典データセット
- uspto-grants-2010_01
- 特許番号
- US07652053B2
反応ノート
読み込み中…